Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Receivables (2022 - 2025)

Envoy Medical's Receivables history spans 4 years, with the latest figure at $54000.0 for Q3 2025.

  • For Q3 2025, Receivables fell 76.42% year-over-year to $54000.0; the TTM value through Sep 2025 reached $54000.0, down 76.42%, while the annual FY2024 figure was $818000.0, 232.52% up from the prior year.
  • Receivables for Q3 2025 was $54000.0 at Envoy Medical, down from $63000.0 in the prior quarter.
  • Across five years, Receivables topped out at $1.1 million in Q3 2023 and bottomed at $41000.0 in Q4 2022.
  • The 4-year median for Receivables is $211500.0 (2024), against an average of $304800.0.
  • The largest annual shift saw Receivables skyrocketed 500.0% in 2023 before it crashed 79.35% in 2024.
  • A 4-year view of Receivables shows it stood at $41000.0 in 2022, then surged by 500.0% to $246000.0 in 2023, then soared by 232.52% to $818000.0 in 2024, then crashed by 93.4% to $54000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Receivables are $54000.0 (Q3 2025), $63000.0 (Q2 2025), and $65000.0 (Q1 2025).